ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/02/22 | 2,720 | 2,814 | 2,704 | 2,793 | +67 | +2.5% | 256,000 |
2016/02/19 | 2,735 | 2,766 | 2,692 | 2,726 | -36 | -1.3% | 233,000 |
2016/02/18 | 2,747 | 2,805 | 2,730 | 2,762 | +84 | +3.1% | 281,800 |
2016/02/17 | 2,762 | 2,781 | 2,644 | 2,678 | -84 | -3% | 288,400 |
2016/02/16 | 2,781 | 2,823 | 2,752 | 2,762 | -22 | -0.8% | 288,100 |
2016/02/15 | 2,758 | 2,801 | 2,701 | 2,784 | +192 | +7.4% | 657,800 |
2016/02/12 | 2,693 | 2,715 | 2,558 | 2,592 | -144 | -5.3% | 778,700 |
2016/02/10 | 2,860 | 2,860 | 2,716 | 2,736 | -108 | -3.8% | 451,100 |
2016/02/09 | 2,909 | 2,919 | 2,826 | 2,844 | -105 | -3.6% | 612,600 |
2016/02/08 | 2,955 | 3,035 | 2,915 | 2,949 | -286 | -8.8% | 781,400 |
2016/02/05 | 3,225 | 3,290 | 3,180 | 3,235 | -10 | -0.3% | 239,800 |
2016/02/04 | 3,350 | 3,350 | 3,205 | 3,245 | -170 | -5% | 324,100 |
2016/02/03 | 3,390 | 3,420 | 3,345 | 3,415 | ±0 | ±0% | 385,000 |
2016/02/02 | 3,345 | 3,430 | 3,345 | 3,415 | +95 | +2.9% | 322,700 |
2016/02/01 | 3,270 | 3,350 | 3,265 | 3,320 | +65 | +2% | 323,200 |
2016/01/29 | 3,260 | 3,265 | 3,180 | 3,255 | +45 | +1.4% | 417,000 |
2016/01/28 | 3,240 | 3,240 | 3,190 | 3,210 | -30 | -0.9% | 383,600 |
2016/01/27 | 3,225 | 3,255 | 3,185 | 3,240 | +80 | +2.5% | 330,300 |
2016/01/26 | 3,165 | 3,190 | 3,125 | 3,160 | -25 | -0.8% | 260,500 |
2016/01/25 | 3,230 | 3,245 | 3,145 | 3,185 | +65 | +2.1% | 283,000 |
2016/01/22 | 3,045 | 3,125 | 3,015 | 3,120 | +163 | +5.5% | 308,600 |
2016/01/21 | 3,035 | 3,095 | 2,957 | 2,957 | -98 | -3.2% | 307,300 |
2016/01/20 | 3,125 | 3,170 | 3,045 | 3,055 | -75 | -2.4% | 266,700 |
2016/01/19 | 3,140 | 3,185 | 3,110 | 3,130 | -35 | -1.1% | 285,100 |
2016/01/18 | 3,150 | 3,180 | 3,125 | 3,165 | -40 | -1.2% | 236,500 |
2016/01/15 | 3,215 | 3,260 | 3,195 | 3,205 | +55 | +1.7% | 351,900 |
2016/01/14 | 3,145 | 3,165 | 3,090 | 3,150 | -55 | -1.7% | 292,800 |
2016/01/13 | 3,185 | 3,220 | 3,155 | 3,205 | +35 | +1.1% | 276,000 |
2016/01/12 | 3,200 | 3,265 | 3,160 | 3,170 | -80 | -2.5% | 317,300 |
2016/01/08 | 3,245 | 3,330 | 3,205 | 3,250 | -5 | -0.2% | 449,300 |
2016/01/07 | 3,235 | 3,300 | 3,220 | 3,255 | -30 | -0.9% | 381,000 |
2016/01/06 | 3,250 | 3,310 | 3,240 | 3,285 | +40 | +1.2% | 230,700 |
2016/01/05 | 3,275 | 3,290 | 3,225 | 3,245 | -60 | -1.8% | 322,200 |
2016/01/04 | 3,330 | 3,385 | 3,290 | 3,305 | -65 | -1.9% | 204,500 |
2015/12/30 | 3,400 | 3,410 | 3,325 | 3,370 | -15 | -0.4% | 209,000 |
2015/12/29 | 3,305 | 3,390 | 3,305 | 3,385 | +30 | +0.9% | 183,800 |
2015/12/28 | 3,370 | 3,410 | 3,305 | 3,355 | +15 | +0.4% | 166,600 |
2015/12/25 | 3,345 | 3,380 | 3,310 | 3,340 | +15 | +0.5% | 102,200 |
2015/12/24 | 3,400 | 3,415 | 3,315 | 3,325 | -35 | -1% | 154,100 |
2015/12/22 | 3,315 | 3,375 | 3,300 | 3,360 | +10 | +0.3% | 428,900 |
2015/12/21 | 3,395 | 3,400 | 3,305 | 3,350 | -105 | -3% | 516,400 |
2015/12/18 | 3,450 | 3,535 | 3,385 | 3,455 | -10 | -0.3% | 559,500 |
2015/12/17 | 3,525 | 3,540 | 3,445 | 3,465 | -10 | -0.3% | 455,900 |
2015/12/16 | 3,500 | 3,510 | 3,425 | 3,475 | +20 | +0.6% | 293,700 |
2015/12/15 | 3,500 | 3,535 | 3,445 | 3,455 | -80 | -2.3% | 364,300 |
2015/12/14 | 3,500 | 3,540 | 3,485 | 3,535 | -5 | -0.1% | 231,000 |
2015/12/11 | 3,565 | 3,630 | 3,510 | 3,540 | +5 | +0.1% | 464,500 |
2015/12/10 | 3,480 | 3,570 | 3,460 | 3,535 | +50 | +1.4% | 543,300 |
2015/12/09 | 3,465 | 3,535 | 3,445 | 3,485 | +30 | +0.9% | 488,900 |
2015/12/08 | 3,465 | 3,500 | 3,435 | 3,455 | -20 | -0.6% | 187,100 |
2251~
2300
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 434,700円 | +20.9% | +87.3% | 3.13% | 9.71倍 | 1.12倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
住友ファーマ | 96,400円 | +26.8% | - | 0.00% | 16.23倍 | 3.35倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 436,500円 | +5.8% | +1.2% | 2.75% | 14.48倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ペプチド | 191,600円 | +5.0% | +1.5% | 0.00% | 16.45倍 | 4.38倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 336,300円 | +8.0% | -15.3% | 3.69% | 9.44倍 | 0.92倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム